Postmenopausal Dyspareunia
📧 Sign up to get email alerts when something new happens for Postmenopausal Dyspareunia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-23FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for OSPHENA (ospemifene) from Duchesnay USA, Inc. to modify the labeling for the product.